Delivery Order SPE2DB22D2007-SPE2DB25FJ4TR
Award Date 9/9/25
Potential Completion Date 9/10/25
Potential Value $36K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $36,187.73 delivery order to AmerisourceBergen Drug Corp for 100 mg vials of Activase, a thrombolytic medication used in acute medical treatment. This competitively awarded, firm fixed-price contract was issued on September 9, 2025, with an ultimate completion date of September 10, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $5,935.94 delivery order to AmerisourceBergen Drug Corp for 50 mg vials of Activase, a thrombolytic medication used in acute medical situations. The contract was competitively awarded without set-aside restrictions and carries a firm fixed price structure with an ultimate completion date of September 11, 2025. AmerisourceBergen will perform this delivery from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Activase 50 mg vials, a thrombolytic medication used in acute medical emergencies. This firm fixed-price delivery order, valued at $3,563.99, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $999,999,999.00 through December 2026. The contract was...
- The Defense Logistics Agency awarded a $13,058.92 delivery order to AmerisourceBergen Drug Corp for 100 mg vials of Activase, a tissue plasminogen activator used for thrombolytic therapy in acute medical emergencies. Issued on September 8, 2025, with completion expected by September 9, 2025, this firm fixed-price contract represents a non-competitive delivery order under the company's existing indefinite delivery contract vehicle. The order will be fulfilled at AmerisourceBergen's corporate...
- The Defense Logistics Agency (DLA) awarded a $11,854.88 delivery order to AmerisourceBergen Drug Corp for the supply of 50 mg vials of Activase, a tissue plasminogen activator used for thrombolytic therapy in acute medical emergencies. This firm fixed-price delivery order, issued on December 6, 2024, with an ultimate completion date of December 9, 2024, was competitively awarded without set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfilled...
- The Defense Logistics Agency awarded a $20,455.11 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Activase 50 mg vials, with an ultimate completion date of August 15, 2025. This is a firm fixed-price, non-set-aside contract issued to the vendor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a $35.5K firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Activase 100 mg vials, with completion scheduled for September 10, 2025. The contract is unclassified as a set-aside and represents a competitively awarded delivery order under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $22,365.75 to AmerisourceBergen Drug Corp for the supply of Activase 50 mg vials. This firm fixed price contract, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The award was made through competitive procurement with no set-aside designation. Performance will take place at...
- This delivery order (4566359301) awards AmerisourceBergen Drug Corp $5,729.42 to supply 50 milligram vials of Activase, a thrombolytic medication used to dissolve blood clots in acute medical emergencies. The contract was awarded on November 7, 2024, with an ultimate completion date of November 8, 2024, and represents a firm fixed-price delivery order with no set-aside designation. The award is funded by the Medical Supply Chain division of the Defense Logistics Agency and will be performed at...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 50 mg vials of Activase on August 20, 2025, with a contract ceiling value of $3,662.41. This firm fixed-price delivery order, which carries an ultimate completion date of August 21, 2025, represents a competitively awarded non-set-aside contract and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is executed under AmerisourceBergen Drug Corp's larger...